These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 18614367

  • 1. Exploring 9-benzyl purines as inhibitors of glutamate racemase (MurI) in Gram-positive bacteria.
    Geng B, Breault G, Comita-Prevoir J, Petrichko R, Eyermann C, Lundqvist T, Doig P, Gorseth E, Noonan B.
    Bioorg Med Chem Lett; 2008 Aug 01; 18(15):4368-72. PubMed ID: 18614367
    [Abstract] [Full Text] [Related]

  • 2. Exploring 8-benzyl pteridine-6,7-diones as inhibitors of glutamate racemase (MurI) in gram-positive bacteria.
    Breault GA, Comita-Prevoir J, Eyermann CJ, Geng B, Petrichko R, Doig P, Gorseth E, Noonan B.
    Bioorg Med Chem Lett; 2008 Dec 01; 18(23):6100-3. PubMed ID: 18947997
    [Abstract] [Full Text] [Related]

  • 3. Potent and selective inhibitors of Helicobacter pylori glutamate racemase (MurI): pyridodiazepine amines.
    Geng B, Basarab G, Comita-Prevoir J, Gowravaram M, Hill P, Kiely A, Loch J, MacPherson L, Morningstar M, Mullen G, Osimboni E, Satz A, Eyermann C, Lundqvist T.
    Bioorg Med Chem Lett; 2009 Feb 01; 19(3):930-6. PubMed ID: 19097892
    [Abstract] [Full Text] [Related]

  • 4. Substituted salicylanilides as inhibitors of two-component regulatory systems in bacteria.
    Macielag MJ, Demers JP, Fraga-Spano SA, Hlasta DJ, Johnson SG, Kanojia RM, Russell RK, Sui Z, Weidner-Wells MA, Werblood H, Foleno BD, Goldschmidt RM, Loeloff MJ, Webb GC, Barrett JF.
    J Med Chem; 1998 Jul 30; 41(16):2939-45. PubMed ID: 9685233
    [Abstract] [Full Text] [Related]

  • 5. Bacterial translation inhibitors, 1-acylindazol-3-ols as anthranilic acid mimics.
    Stiff C, Graber DR, Thorarensen A, Wakefield BD, Marotti KR, Melchior EP, Sweeney MT, Han F, Rohrer DC, Zurenko GE, Romero DL.
    Bioorg Med Chem Lett; 2008 Dec 01; 18(23):6293-7. PubMed ID: 18951783
    [Abstract] [Full Text] [Related]

  • 6. Pleuromutilin derivatives having a purine ring. Part 1: new compounds with promising antibacterial activity against resistant Gram-positive pathogens.
    Hirokawa Y, Kinoshita H, Tanaka T, Nakamura T, Fujimoto K, Kashimoto S, Kojima T, Kato S.
    Bioorg Med Chem Lett; 2008 Jun 15; 18(12):3556-61. PubMed ID: 18511280
    [Abstract] [Full Text] [Related]

  • 7. Exiguaquinol: a novel pentacyclic hydroquinone from Neopetrosia exigua that inhibits Helicobacter pylori MurI.
    de Almeida Leone P, Carroll AR, Towerzey L, King G, McArdle BM, Kern G, Fisher S, Hooper JN, Quinn RJ.
    Org Lett; 2008 Jun 19; 10(12):2585-8. PubMed ID: 18489104
    [Abstract] [Full Text] [Related]

  • 8. Indole naphthyridinones as inhibitors of bacterial enoyl-ACP reductases FabI and FabK.
    Seefeld MA, Miller WH, Newlander KA, Burgess WJ, DeWolf WE, Elkins PA, Head MS, Jakas DR, Janson CA, Keller PM, Manley PJ, Moore TD, Payne DJ, Pearson S, Polizzi BJ, Qiu X, Rittenhouse SF, Uzinskas IN, Wallis NG, Huffman WF.
    J Med Chem; 2003 Apr 24; 46(9):1627-35. PubMed ID: 12699381
    [Abstract] [Full Text] [Related]

  • 9. Structure-based design of a new series of D-glutamic acid based inhibitors of bacterial UDP-N-acetylmuramoyl-L-alanine:D-glutamate ligase (MurD).
    Tomasić T, Zidar N, Sink R, Kovac A, Blanot D, Contreras-Martel C, Dessen A, Müller-Premru M, Zega A, Gobec S, Kikelj D, Masic LP.
    J Med Chem; 2011 Jul 14; 54(13):4600-10. PubMed ID: 21591605
    [Abstract] [Full Text] [Related]

  • 10. Exploitation of structural and regulatory diversity in glutamate racemases.
    Lundqvist T, Fisher SL, Kern G, Folmer RH, Xue Y, Newton DT, Keating TA, Alm RA, de Jonge BL.
    Nature; 2007 Jun 14; 447(7146):817-22. PubMed ID: 17568739
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Solid-phase synthesis of polyfunctionalized natural products: application to usnic acid, a bioactive lichen compound.
    Tomasi S, Picard S, Lainé C, Babonneau V, Goujeon A, Boustie J, Uriac P.
    J Comb Chem; 2006 Jun 14; 8(1):11-4. PubMed ID: 16398547
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antibacterial activity of pyrrolopyridine-substituted oxazolidinones: synthesis and in vitro SAR of various C-5 acetamide replacements.
    Paget SD, Boggs CM, Foleno BD, Goldschmidt RM, Hlasta DJ, Weidner-Wells MA, Werblood HM, Bush K, Macielag MJ.
    Bioorg Med Chem Lett; 2006 Sep 01; 16(17):4537-42. PubMed ID: 16806921
    [Abstract] [Full Text] [Related]

  • 16. Design of Helicobacter pylori glutamate racemase inhibitors as selective antibacterial agents: a novel pro-drug approach to increase exposure.
    Basarab GS, Hill PJ, Rastagar A, Webborn PJ.
    Bioorg Med Chem Lett; 2008 Aug 15; 18(16):4716-22. PubMed ID: 18640833
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and antibacterial activity of nocathiacin I analogues.
    Naidu BN, Sorenson ME, Matiskella JD, Li W, Sausker JB, Zhang Y, Connolly TP, Lam KS, Bronson JJ, Pucci MJ, Yang H, Ueda Y.
    Bioorg Med Chem Lett; 2006 Jul 01; 16(13):3545-9. PubMed ID: 16621551
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.